SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which in turn can activate MUP9. PKC phosphorylates specific serine/threonine residues on target proteins, leading to the activation of MUP9 by modifying its conformation and functional state. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1, a potent modulator of PKC, indirectly activates MUP9 by binding to the regulatory domain of PKC. This binding enhances PKC's catalytic activity, resulting in the phosphorylation and consequent activation of MUP9. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium activates calmodulin, which in turn can activate various kinases such as CaMKII that phosphorylate and activate MUP9. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases leads to increased phosphorylation levels of several proteins, potentially including MUP9, thereby promoting its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. This can activate calcium-dependent kinases, which may phosphorylate and activate MUP9. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, activates PKA. PKA then phosphorylates various substrates, potentially including MUP9, resulting in its activation. This compound serves as a stable mimic of cAMP, enhancing PKA's activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a potent PKC inhibitor, can paradoxically activate PKC at low concentrations. This activation may lead to the phosphorylation and subsequent activation of MUP9 through PKC's kinase activity. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
Phorbol 12,13-dibutyrate (PDBu) is a PKC activator. It binds to the regulatory domain of PKC, promoting its activation. Activated PKC may then phosphorylate and activate MUP9. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C, a PKC inhibitor, can activate PKC at specific concentrations. This activation leads to phosphorylation of target proteins, potentially including MUP9, thus promoting its functional activation. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go 6983 is a pan-PKC inhibitor that, under certain conditions, can activate PKC. This activation can lead to the phosphorylation of several proteins, including MUP9, enhancing its activation. | ||||||